TUESDAY, DECEMBER 6, 2016

Summit highlights advances in avian flu vaccine research

One Health Summit, a yearly BioKansas conference that exchanges knowledge about improving and strengthening public safety, recently released further information about a novel method for developing avian influenza vaccines (AIV). Read More »

First measles case of 2015 confirmed in Massachusetts

A recent announcement from the Hinton State Laboratory has confirmed the first measles case for 2015 in the state of Massachusetts. Read More »

Polio vaccine beginning of adequate health care in Africa

According to an advocacy report recently released by the International Federation of Red Cross and Red Crescent Societies (IFRC), eliminating polio is just the beginning of providing adequate health care to people in Africa. Read More »

I-STAR Technology may identify effective therapies against Ebola

A recent announcement states that Theraclone Science Inc., a company specializing in therapeutic antibody discovery and development, has created I-STAR Technology to identify possible therapeutic antibodies to fight against Ebola. Read More »

GlaxoSmithKline announces influenza vaccine supply update

GlaxoSmithKline (GSK) recently announced that the supply of its new quadrivalent influenza vaccine, called Fluarix Tetra, is no longer available in Australia’s private markets. Read More »

Indonesia hosts conference on typhoid, Invasive NTS Disease

Bali, Indonesia, hosted the 9th International Conference on Typhoid and Invasive NTS Disease, hosted by Bio Farma and the Coalition against Typhoid (CaT), over the weekend. Experts estimate that typhoid infects approximately 21 million people around the world annually, killing more than 216,000. Most who die are under 15 years old. Read More »

AutoGenomics begins new Hepatitis C virus genotyping test

AutoGenomics Inc., one of the top providers of automated molecular testing solutions, recently announced the launch of its Genotyping Hepatitis C Virus (HCV) test with the company’s INFINITI Plus and INFINITI High Throughput System. Read More »

Benitec Biopharma expands hepatitis C trial

Benitec Biopharma, a biopharmaceutical company that specializes in producing potentially curing therapies and a proprietary gene-silencing technology named ddRNAi, has continued its hepatitis C virus (HCV) infection clinical trial by administering the fifth human subject with a Phase I/IIa dose increase. Read More »

Eskitis Institute receives additional finances for malaria research

Griffith University’s Eskitis Institute for Drug Discovery said Friday it has received additional funding from the Global Health Innovative Technology Fund (GHIT) in Japan for malaria research. Read More »

Probable bird flu cases reported in 4 Iowa counties

Four potential cases of highly contagious avian influenza have been detected in Iowa’s Cherokee, Pocahontas, Sac, and Madison counties, the Iowa Department of Agriculture said Friday.  Read More »

AIDS Healthcare Foundation supports new implant to deliver HIV treatment

The AIDS Healthcare Foundation President Michael Weinstein (AHF) recently announced that it supports the development of a new implant that delivers drugs to treat HIV. Read More »

Canadian government financially supports influenza vaccine research

A recent announcement states that the Canadian government has invested approximately $1 million in financial support for the research and development of a vaccine for influenza. Read More »

Human pneumonic plague outbreak has multiple transmission routes

According to a recent announcement from the Colorado Department of Public Health and Environment (CDPHE) laboratory, the recent outbreak of pneumonic plague can be transmitted from human to human as well as dog to human. Read More »

Iowa congressman weighs in after avian-flu state of emergency declared

U.S. Rep. Steve King (R-IA) released a statement on Friday on Iowa's state of emergency that was issued over an outbreak of avian influenza H5N2. Iowa Gov. Terry Branstad issued the state-of-emergency directive, along with Mark Schouten, director of Iowa's Homeland Security and Emergency Management Department, and Bill Northey, Iowa's agriculture secretary. Read More »

Drug-resistant bacteria more common among dementia patients in nursing homes

Study finds 1 in 5 dementia patients test positive for drug-resistant bacteria. Read More »

Silicon microparticles may improve cancer vaccines

A team of scientists from Houston Methodist, as well as from other institutions, recently reported that the efficiency of cancer vaccines may be improved if cancer antigens were first loaded into silicon microparticles. Read More »

Interferon-free therapy treats hepatitis C in trial

A recent trial shows that interferon-free therapy has cleared hepatitis C from 93 percent of the patients involved in the trial. Read More »

Minnesota updates avian influenza cases

The Minnesota Board of Animal Health said Monday that there have been eight presumptive positive flocks for avian influenza. Affected Minnesota counties include Nicollet (1,102,900 chickens infected), Renville (12,900 turkeys), Kandiyohi (over 100,000 turkeys), Swift (46,200 turkeys) and Pipestone (72,200 turkeys). More than 5.3 million birds have been infected with avian influenza; this figure excludes flocks that still need to be tested for the virus. Read More »

Aid group targets pneumococcal diseases in South Sudan refugees

Medecins San Frontieres (Doctors Without Borders) teams based in Ethiopia’s Gambella region said on Tuesday that they will expand the vaccination packages that they offer refugees from South Sudan to include Hib (Haemophilus influenza type B) and PCV (Pneumococcal conjugate vaccine) in an effort to decrease child deaths from pneumococcal diseases. Read More »

New firm to create vaccines to prevent cytomegalovirus infections

DiaVax Biosciences, a new company created by City of Hope and Fortress Biotech, will create two vaccines to protect those with weak immune systems against cytomegalovirus (CMV) infections. CMV is a life-threatening illness that commonly afflicts people who have underdeveloped or weakened immune systems, such as developing fetuses and cancer patients. Read More »